Podrobno

Homodimerizacija proteina ORF1p iz LINE-1 v presejalnih sistemih s ToxR in LexA v E. coli
ID Osterc, Igor (Avtor), ID Župunski, Vera (Mentor) Več o mentorju... Povezava se odpre v novem oknu

.pdfPDF - Predstavitvena datoteka, prenos (2,50 MB)
MD5: 7F62BC4E8100A50C6F6F21156F4744CE

Izvleček
Retrotranspozon LINE1 je edini samostojno aktiven mobilni genetski element v človeškem genomu. Zaporedje LINE1 zapisuje za proteine ORF0p, ORF1p in ORF2p. Protein ORF1p v aktivni obliki tvori homotrimere, ki v sodelovanju z ORF2p izvedejo celoten proces retrotranspozicije. ORF1p veže lastno kodirajočo mRNA in deluje kot šaperon nukleinskih kislin. Odgovoren je za tvorbo ribonukleoproteinskega (RNP) kompleksa. Sistema LexA in ToxR sta bila ustvarjena z namenom zaznavanja homodimerizacije proteinov. Temeljita na bakterijskih transkripcijskih faktorjih LexA in ToxR. Ta sta aktivna v homodimerni obliki in sta sestavljena iz DNA vezavne ter dimerizacijske domene. Če namesto dimerizacijske domene LexA oz. ToxR vstavimo zapis za izbrani protein, lahko na podlagi signala, ki nam ga da reporterski protein, določimo, ali vstavljen protein homodimerizira ali ne. Z namenom določitve homodimerizacije proteina ORF1p smo zapis za protein klonirali v sistema LexA in ToxR. Prav tako smo za primerjavo v oba sistema klonirali zapis za mutirano obliko proteina z imenom JMIII. Poleg tega smo določali dimerizacijo tudi skrajšanima zapisoma za ORF1p in JMIII, katerima smo iz izhodnih zapisov odstranili zapis za neurejene dele na N-koncu. Rezultati so pokazali razliko med sistemoma LexA in ToxR. ORF1p je v sistemu LexA pokazal določeno stopnjo homodimerizacije, medtem ko je mutirana oblika JMIII ni. V sistemu ToxR tako ORF1p kot tudi JMIII nista homodimerizirala. V nadaljnjih poskusih smo z odstranitvijo neurejenih delov proteinov ORF1p in JMIII zagotovili večjo uspešnost uporabljenih sistemov. Rezultati skrajšanih oblik so namreč pokazali višjo stopnjo homodimerizacije ORF1p v sistemu LexA, JMIII pa enako kot prej ni tvoril homodimerov. Razlike med ORF1p in JMIII v sistemu LexA nakazujejo, da se mutacije nahajajo na strukturno pomembnih delih proteina, ki so ključni za povezovanje v višje strukture. V sistemu ToxR smo s skrajšanjem zaporedij proteinov zagotovili homodimerizacjo tako ORF1p kot tudi JMIII. Predpostavili smo, da je do razlik med rezultati sistemov LexA in ToxR verjetno prišlo zaradi mutacije v promotorju ToxR sistema ToxR, ki smo jo kasneje dokazali s poravnavo zaporedij. Postopke bi morali dodatno optimizirati, da bi dobili bolj jasne rezultate homodimerizacije naših dveh proteinov. Prav tako bi bilo potrebno uporabljeno metodo za ugotavljanje homodimerizacije preveriti še na kakšnem homotrimeru.

Jezik:Slovenski jezik
Ključne besede:ORF1p, LINE1, homodimerizacija, LexA, ToxR
Vrsta gradiva:Diplomsko delo/naloga
Tipologija:2.11 - Diplomsko delo
Organizacija:FKKT - Fakulteta za kemijo in kemijsko tehnologijo
Leto izida:2026
PID:20.500.12556/RUL-184562 Povezava se odpre v novem oknu
COBISS.SI-ID:288473347 Povezava se odpre v novem oknu
Datum objave v RUL:10.07.2026
Število ogledov:186
Število prenosov:78
Metapodatki:XML DC-XML DC-RDF
:
Kopiraj citat
Objavi na:Bookmark and Share

Sekundarni jezik

Jezik:Angleški jezik
Naslov:Homodimerization of the LINE-1 ORF1p in ToxR and LexA screening systems in E. coli
Izvleček:
LINE1 retrotransposon is the only autonomous mobile genetic element in the human genome. The LINE1 sequence encodes proteins ORF0p, ORF1p and ORF2p. In its active state, the ORF1p protein forms homotrimers which, together with ORF2p, carry out the entire process of retrotransposition. ORF1p binds its own coding mRNA and functions as a nucleic acid chaperone. It is responsible for the formation of the ribonucleoprotein particle (RNP). LexA and ToxR screening systems were developed for the detection of protein homodimerization. They are based on bacterial transcription factors LexA and ToxR. Both of them are active in their homodimeric forms and consist of DNA binding domain and a dimerization domain. By replacing the dimerization domain of LexA or ToxR with the coding sequence of any protein of interest, it is possible to determine whether the inserted protein homodimerizes or not. This is done based on the signal produced by a reporter protein in the systems. To analyse homodimerization degree of the ORF1p, the corresponding coding sequence was cloned into the LexA and ToxR systems. For comparison, the coding sequence of a mutant form of the protein, designated JMIII, was also cloned into both systems. Furthermore, truncated versions of ORF1p and JMIII were cloned into the systems. In comparison to the original sequences of ORF1p and JMIII, truncated versions lacked the coding regions for the flexible parts of the proteins. The results revealed differences between the LexA and ToxR systems. In the LexA system, ORF1p exhibited a certain degree of homodimerization, whereas the mutant JMIII did not. In the ToxR system, neither ORF1p nor JMIII showed homodimerization. In following studies, removal of the flexible regions from ORF1p and JMIII improved the performance of the systems. Truncated ORF1p variant exhibited a higher degree of homodimerization in the LexA system, while JMIII, same as before, failed to form homodimers. The differences observed between ORF1p and JMIII in the LexA system suggest that the mutations are located within structurally important regions of the protein, which are essential for assembly into higher order structures. In the ToxR system, truncation of protein sequences resulted in homodimerization of both ORF1p and JMIII. We suggested that the differences in results between both systems were most likely caused by a mutation within ToxR promoter of the ToxR system. The mutation was later confirmed by sequence alignment analysis. Because of that further studies would be required to achieve deeper characterization of the used systems for our proteins. In addition, the method used for detecting homodimerization should be validated using another homotrimeric protein.

Ključne besede:ORF1p, LINE1, homodimerization, LexA, ToxR

Podobna dela

Podobna dela v RUL:
Podobna dela v drugih slovenskih zbirkah:

Nazaj